Lung Disease Current Events | Lung Disease News | 11
|
| Page
11 of
38 |
755 Results |
|
|
|
Sort By:
Page Views | Date |
Clear public health message on cannabis needed
Smoking cannabis, like smoking tobacco, can be a major public health hazard but, at present, there is no clear public health message about cannabis, argue researchers in this week's BMJ. The number of cannabis smokers is increasing. Between 1999 and 2001, the number of 14-15 year olds who had tried cannabis rose from 19% to 29% in boys and 18% to... view more... (2003-04-30)
Scientists show gene mutation may cause immature lungs in newborns
Scientists have identified a gene critical to lung maturation in newborns and the production of surfactant, which lines lung tissues and prevents the lungs from collapsing. view more (2008-11-25)
Advances in lung cancer research announced at conference
Dr. Glen Weiss of the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare this week announced two significant advances in treating lung cancer at an international cancer research conference. view more (2009-08-10)
New approach allows closer look at smoker lungs
Aided by a powerful imaging technique, scientists have discovered they can detect smoking-related lung damage in healthy smokers who otherwise display none of the telltale signs of tobacco use. view more (2006-05-31)
Lung cancer survival better in women
Women with lung cancer are living longer than men, even when the disease is untreated. view more (2005-11-02)
High-dose radiation improves lung cancer survival, U-M study finds
Higher doses of radiation combined with chemotherapy improve survival in patients with stage III lung cancer, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center. view more (2009-04-09)
Faulty cell cycle checkpoints linked to lung cancer risk in African-Americans
Faulty cell cycle "checkpoints" that fail to respond to DNA damage effectively may contribute to the high incidence of lung cancer in African-Americans. view more (2005-10-17)
Vaporized viral vector shows promise in anti-cancer gene therapy
A new lung cancer therapy employing a vaporized viral vector to deliver a cancer-inhibiting molecule directly to lung tissue shows early promise in mouse trials, according to researchers at the Ministry of Education, Science and Technology in Korea. view more (2009-06-09)
Extra-aggressive form of idiopathic pulmonary fibrosis identified
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disorder from which most patients die within 5 years after diagnosis. The disease is characterized by the insidious onset of dyspnea or cough and usually evolves slowly. view more (2007-05-30)
Shorter distance on six-minute walk test points up a greater risk of death
For idiopathic pulmonary fibrosis (IPF) patients awaiting lung transplantation, a simple walk test can predict mortality rates. view more (2006-09-18)
Study finds that practice makes perfect in lung cancer surgery
Patients operated on by surgeons who do not routinely remove cancer from the lungs may be at a higher risk for complications, according to a study conducted by researchers at Duke University Medical Center. view more (2008-10-24)
Gene panel predicts lung cancer survival, study finds
Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment. view more (2008-07-22)
Early exposure to tobacco smoke may lead to early emphysema later
Chronic exposure to tobacco smoke in childhood may contribute to early emphysema later in life, according to new research. view more (2009-05-20)
Biomarkers identified for idiopathic pulmonary fibrosis
The first evidence of a distinctive protein signature that could help to transform the diagnosis and improve the monitoring of the devastating lung disease idiopathic pulmonary fibrosis (IPF) is being reported by University of Pittsburgh School of Medicine researchers in this month's edition of PLoS Medicine, an open-access journal of the Public... view more... (2008-04-29)
Mutation database helps personalized treatment of lung cancer
A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in... view more... (2008-04-25)
Cancer immunotherapy shows long-term promise in lung cancer
New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung... view more... (2008-04-25)
Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers
Researchers at Henry Ford Hospital today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new option for those suffering with advanced emphysema. view more (2008-03-13)
Beta carotene slows decline in lung power associated with ageing
Beta carotene, a precursor to vitamin A, slows the decline in lung power associated with ageing, reveals research in Thorax. view more (2006-03-23)
High-dose inhaled corticosteroid use for COPD could cut risk of lung cancer
Among a group of mostly older male veterans suffering from chronic obstructive pulmonary disease (COPD), an illness that offers a greater susceptibility to lung cancer, researchers found that regular use of high dose inhaled corticosteroids (ICS) lowered the risk of developing lung cancer. view more (2007-04-02)
New York Methodist Hospital to study airway bypass treatment for emphysema
New York Methodist Hospital today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new, minimally-invasive option for those suffering with advanced widespread emphysema. view more (2008-02-05)
|
|
| Page
11 of
38 |
755 Results |
|
|
|
Sort By:
Page Views | Date |
|
